Innovotech Secures $600,000 in Credit Facilities from ATB

EDMONTON, Alberta, October 29, 2026 - TheNewswire, Innovotech Inc., a life sciences services and technology company focused on applied microbiology, analytical chemistry, and regulated laboratory services, has established a new banking partnership with ATB Financial. The arrangement includes a $500,000 revolving operating line of credit and a $100,000 corporate credit card facility.

Innovotech, which has built its laboratory business in Edmonton for more than two decades, serving medical device, pharmaceutical, and healthcare clients in Canada and around the world, is leveraging these credit facilities to support its continued growth. The new partnership with ATB, a financial institution that has supported Albertans and Alberta businesses since 1938, will provide Innovotech with flexible, non-dilutive working capital.

Craig Milne, CEO of Innovotech, expressed satisfaction with the new banking arrangement.

The credit facilities will support Innovotech’s commercial rollout of its InnovoTEST™ Hazardous Drug Wipe Testing Kits and the expansion of its contract research and laboratory testing services. As part of the transition, Innovotech will consolidate its day-to-day banking with ATB, simplifying its banking arrangements by closing a number of legacy accounts and smaller facilities. The Company expects the consolidation to reduce administrative effort and banking costs and to give management a clearer, single view of its cash position.

Innovotech, a leading life sciences services and technology company, specializes in contract research, analytical, and microbial testing within regulated healthcare markets. The Company is a recognized leader in biofilm science and antimicrobial testing and provides advanced laboratory services supporting medical device, pharmaceutical, and industrial product development. Operating through ISO-certified and GMP-accredited laboratories, Innovotech supports clients across multiple sectors and geographies, delivering reliable, decision-enabling data aligned with regulatory expectations such as those of the U.S. Food and Drug Administration and Health Canada.

The partnership brings together two Alberta institutions with Edmonton roots. ATB has supported Albertans and Alberta businesses since 1938, and Innovotech has built its laboratory business in Edmonton for more than two decades, serving medical device, pharmaceutical, and healthcare clients in Canada and around the world.